KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 13 filers reported holding KRYSTAL BIOTECH INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $580,000 | -61.9% | 8,320 | -61.8% | 0.00% | -25.0% |
| Q4 2021 | $1,524,000 | +126.4% | 21,794 | +69.1% | 0.00% | +100.0% |
| Q3 2021 | $673,000 | +119.9% | 12,885 | +186.3% | 0.00% | +100.0% |
| Q2 2021 | $306,000 | +28.6% | 4,501 | -21.8% | 0.00% | -75.0% |
| Q2 2020 | $238,000 | -63.4% | 5,758 | -51.0% | 0.00% | 0.0% |
| Q4 2019 | $651,000 | -41.2% | 11,762 | -63.1% | 0.00% | -60.0% |
| Q3 2019 | $1,108,000 | -30.2% | 31,909 | -19.1% | 0.01% | -33.3% |
| Q2 2019 | $1,588,000 | +625.1% | 39,428 | +492.8% | 0.02% | +650.0% |
| Q1 2019 | $219,000 | +92.1% | 6,651 | -38.4% | 0.00% | 0.0% |
| Q4 2017 | $114,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |